Literature DB >> 8870681

The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes.

J Garriga1, X Mayol, X Graña.   

Abstract

PITALRE is a human protein kinase identified by means of its partial sequence identity to the cell division cycle regulatory kinase CDC2. Immunopurified PITALRE protein complexes exhibit an in vitro kinase activity that phosphorylates the retinoblastoma protein, suggesting that PITALRE catalyses this phosphorylation reaction. However, the presence of other kinases in the immunopurified complex could not be ruled out. In the present work, an inactive mutant of the PITALRE kinase has been used to demonstrate that PITALRE is the catalytic subunit responsible for the PITALRE-complex-associated kinase activity, Ectopic overexpression of PITALRE did not increase the total PITALRE kinase activity in the cell, suggesting that PITALRE is regulated by limiting cellular factor(s). Characterization of the PITALRE-containing protein complexes indicated that most of the cellular PITALRE protein exists as a subunit in at least two different active multimeric complexes. Although monomeric PITALRE is also active in vitro, PITALRE present in multimeric complexes exhibits several-fold higher activity than monomeric PITALRE. In addition, overexpression of PITALRE demonstrated the existence of two new associated proteins of approx. 48 and 98 kDa. Altogether these results suggest that, in contrast to the situation with cyclin-dependent kinases, monomeric PITALRE is active, and that association with other proteins modulates its activity and/or its ability to recognize substrates in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870681      PMCID: PMC1217767          DOI: 10.1042/bj3190293

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  MAP kinases: charting the regulatory pathways.

Authors:  S L Pelech; J S Sanghera
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

Review 2.  Dual-specificity protein kinases: will any hydroxyl do?

Authors:  R A Lindberg; A M Quinn; T Hunter
Journal:  Trends Biochem Sci       Date:  1992-03       Impact factor: 13.807

3.  Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle.

Authors:  B A Bunnell; L S Heath; D E Adams; J M Lahti; V J Kidd
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

Authors:  W G Kaelin; D C Pallas; J A DeCaprio; F J Kaye; D M Livingston
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

Review 5.  Cyclins and cyclin-dependent kinases: take your partners.

Authors:  J Pines
Journal:  Trends Biochem Sci       Date:  1993-06       Impact factor: 13.807

6.  PISSLRE, a human novel CDC2-related protein kinase.

Authors:  X Graña; P P Claudio; A De Luca; N Sang; A Giordano
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

7.  PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.

Authors:  X Graña; A De Luca; N Sang; Y Fu; P P Claudio; J Rosenblatt; D O Morgan; A Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Molecular cloning of PISSLRE, a novel putative member of the cdk family of protein serine/threonine kinases.

Authors:  R Brambilla; G Draetta
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

9.  PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family.

Authors:  T Okuda; J L Cleveland; J R Downing
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

10.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

View more
  35 in total

1.  E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein.

Authors:  M Parreño; J Garriga; A Limón; X Mayol; G R Beck; E Moran; X Graña
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.

Authors:  Siobhan K O'Brien; Hong Cao; Robin Nathans; Akbar Ali; Tariq M Rana
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

4.  Recruitment of P-TEFb (Cdk9-Pch1) to chromatin by the cap-methyl transferase Pcm1 in fission yeast.

Authors:  Allan Guiguen; Julie Soutourina; Monique Dewez; Lionel Tafforeau; Marc Dieu; Martine Raes; Jean Vandenhaute; Michel Werner; Damien Hermand
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

5.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 6.  Functional evolution of cyclin-dependent kinases.

Authors:  John H Doonan; Georgios Kitsios
Journal:  Mol Biotechnol       Date:  2009-01-15       Impact factor: 2.695

7.  Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.

Authors:  Sabine Rechter; Gillian M Scott; Jan Eickhoff; Katrin Zielke; Sabrina Auerochs; Regina Müller; Thomas Stamminger; William D Rawlinson; Manfred Marschall
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

8.  MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.

Authors:  Annemieke A Michels; Van Trung Nguyen; Alessandro Fraldi; Valérie Labas; Mia Edwards; François Bonnet; Luigi Lania; Olivier Bensaude
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  The C-terminal domain of pol II and a DRB-sensitive kinase are required for 3' processing of U2 snRNA.

Authors:  Joanne E Medlin; Patricia Uguen; Alice Taylor; David L Bentley; Shona Murphy
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

10.  Selective control of gene expression by CDK9 in human cells.

Authors:  Judit Garriga; Hongbo Xie; Zoran Obradovic; Xavier Graña
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.